Robert Lakin

Robert Lakin

InvestorPlace Contributor

A journalist — both writer and editor — Robert has covered markets and economies for more than 20 years. His previous gigs include Bloomberg News, where he was emerging markets editor in Tel Aviv, McKinsey & Co. and McDonald & Company Investments, where he was equities research editor.

His deep experience includes covering startups, emerging markets, financial services, and capital markets.

He writes a Substack newsletter, TLV Strategist, which covers the Israel business scene.

Recent Articles

Nvidia Stock Split 2021: What NVDA Investors Should Know as the 4-for-1 Split Goes Into Effect

By Robert Lakin, InvestorPlace Contributor

Nvidia shares are set to trade on a post-split basis today, after management completed a 4-for-1 move to make NVDA stock more affordable.

5 Luxury Stocks to Buy as ‘Revenge Spending’ Soars

By Robert Lakin, InvestorPlace Contributor

With economies re-opening, consumers are on a tear with their 'revenge spending'. These 5 stocks will likely benefit from the surge.

VERB Stock: How a ‘UFO’ Got Verb Technology Shares Soaring Again

By Robert Lakin, InvestorPlace Contributor

VERB stock is surging on news of a partnership with Shop.com, which will result in a new customized, interactive live-streaming channel.

NFLX Stock: The Streaming Video Game News That Has All Eyes on Netflix Today

By Robert Lakin, InvestorPlace Contributor

NFLX stock is surging ahead this morning as the company looks to expand into video games. Here's what investors need to know.

VLDR Stock: The Big Nvidia News That Has Velodyne Lidar Shares Surging Today

By Robert Lakin, InvestorPlace Contributor

The autonomous driving race is on, and lidar tech will be key to winning. That said, let's look at why VLDR stock just got a major boost.

Airline Stocks: What’s Moving DAL, AAL and UAL Today

By Robert Lakin, InvestorPlace Contributor

Airline stocks are starting to breathe a sigh of relief. But it might be too soon, as Covid-19 and the delta variant threaten travel.

CLOV Stock: Why One Analyst Is Now Souring on Clover Health

By Robert Lakin, InvestorPlace Contributor

JPMorgan told clients to "underweight" Clover Health after the Medicare management firm lowered most guidance metrics. It knocked the CLOV stock price target down to $9 a share.

NOK Stock: The Big News That Has the Reddit Favorite Gaining Today

By Robert Lakin, InvestorPlace Contributor

Meme favorite Nokia will raise its full-year outlook as business picked up in the second quarter. That's got NOK stock surging ahead of Tuesday's U.S. market open.

LCAP Stock: What to Know About Lionheart Acquisition and the MSP Recovery SPAC Merger

By Robert Lakin, InvestorPlace Contributor

News of the Lionheart-MSP deal comes as more than 420 SPACs are now searching for a private company to take public and another 295 with pending IPOs. Will this be what takes LCAP stock higher?

Space Stocks: The Milestone That Has VACQ, ASTR, ASTS Stocks Gaining Today

By Robert Lakin, InvestorPlace Contributor

The Virgin Galactic flight is being heralded as a milestone for commercial space flight. That's got space stocks ASTS, ASTR and VACQ gaining in Monday's pre-market trading.

Load More